References
- Nishiyama M. Preterm birth prevention and 17P injection treatment education workshop; 2017 [cited 2017 Aug 8].
- Bernstein P. 17OHPC [Video file]. Previous preterm birth; 2014 [cited 2019 Jan 1]. Available from: https://www.acog.org/About-ACOG/ACOG-Districts/District-II/Preventing-Preterm-Birth-For-Providers.
- The impact of premature birth on society. Fighting premature birth: The Prematurity Campaign; 2015. Available from: marchofdimes.org. In: March of Dimes; October 2015.
- American College of Obstetrics and Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol. 2012;120(4):964–973.
- Office of Disease Prevention and Health Promotion. Maternal, infant, and child health. Healthy people 2020; 2017 [cited 2019 April 25]. Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/maternal-infant-and-child-health
- Anderson J, Andrews S, Bakulski M, et al. Recommendations to reduce preterm birth in Colorado. Colorado Department of Public Health and Environment; 2017 [cited 2018]. Available from: www.copretermbirth.org
- Hickok D. 17 alpha-hydroxyprogesterone caproate injection, 250 mg/mL NDA 21-945 [PDF]. Marlborough (MA): Advisory Committee Meeting: Reproductive Health Drugs; 2006.
- Norwitz ER, Caughey AB. Progesterone supplementation and the prevention of preterm birth. Rev Obstet Gynecol. 2011;4:60–72.
- Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348:2379–2385.
- Stringer EM, Vladutiu CJ, Manuck T, et al. 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: a retrospective cohort study. Am J Obstet Gynecol. 2016;215:105.e1–105.e12.